shutterstock_570111292-stepan-lytovchenko
Stepan Lytovchenko / Shutterstock.com
1 August 2019AmericasSarah Morgan

Trump confounds big pharma with low-cost drugs import plan

In a bid to lower drug prices for American patients, the Trump administration has proposed plans to allow the importation of cheaper drugs from Canada and other countries.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
9 September 2019   Innovative Medicines Canada, an association that represents drugmakers in Canada, has challenged the overhaul of Canada’s drug-pricing regime.
Americas
20 September 2019   The Biotechnology Innovation Organization has claimed that if the drug pricing plan unveiled by US House of Representatives Speaker Nancy Pelosi yesterday, September 19, becomes law, it will upend the US’s ability to lead the world in biomedical innovation.

More on this story

Americas
9 September 2019   Innovative Medicines Canada, an association that represents drugmakers in Canada, has challenged the overhaul of Canada’s drug-pricing regime.
Americas
20 September 2019   The Biotechnology Innovation Organization has claimed that if the drug pricing plan unveiled by US House of Representatives Speaker Nancy Pelosi yesterday, September 19, becomes law, it will upend the US’s ability to lead the world in biomedical innovation.

More on this story

Americas
9 September 2019   Innovative Medicines Canada, an association that represents drugmakers in Canada, has challenged the overhaul of Canada’s drug-pricing regime.
Americas
20 September 2019   The Biotechnology Innovation Organization has claimed that if the drug pricing plan unveiled by US House of Representatives Speaker Nancy Pelosi yesterday, September 19, becomes law, it will upend the US’s ability to lead the world in biomedical innovation.